| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/2003 | CA2457317A1 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 02/27/2003 | CA2457301A1 Porcine leptin protein, antisense and antibody |
| 02/27/2003 | CA2457298A1 Novel human collagen proteins and polynucleotides encoding the same |
| 02/27/2003 | CA2457236A1 Premeabilisation of cells |
| 02/27/2003 | CA2457226A1 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 02/27/2003 | CA2457163A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | CA2457143A1 In situ immunization |
| 02/27/2003 | CA2457095A1 Zinc finger domain libraries |
| 02/27/2003 | CA2457066A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | CA2457065A1 Periostin-based diagnostic assays |
| 02/27/2003 | CA2457060A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
| 02/27/2003 | CA2456746A1 Method for treating lung cancers |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456334A1 Molecular characteristics of non-small cell lung cancer |
| 02/27/2003 | CA2456201A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454860A1 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2451998A1 Anti-a.beta. antibodies |
| 02/27/2003 | CA2450215A1 Method of labelling crnas for probing oligo-based microarrays |
| 02/27/2003 | CA2446848A1 Derivatives of magainin |
| 02/26/2003 | WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | EP1286165A2 Neuropeptide receptor and uses thereof |
| 02/26/2003 | EP1286163A2 Evaluation of agents for treatment of Schizophrenia |
| 02/26/2003 | EP1285970A2 Metastasis-associated genes |
| 02/26/2003 | EP1285967A2 Human retroviral packaging cell line |
| 02/26/2003 | EP1285966A1 Methods and gene constructs for gene silencing in transgenic plants |
| 02/26/2003 | EP1285965A1 Bifactorial endosperm box, trans-activating factor that binds thereto, and method of regulation of promoter activity |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285963A1 Human ZZAP1 protein |
| 02/26/2003 | EP1285962A1 NADH oxidase from Lactobacillus |
| 02/26/2003 | EP1285960A2 Virulence genes from Salmonella typhimurium |
| 02/26/2003 | EP1285942A1 Polypeptide derivatives and nucleic acid carriers containing the same |
| 02/26/2003 | EP1285930A2 Human antibodies that bind human TNFalpha |
| 02/26/2003 | EP1285929A1 96895, A human sodium-hydrogen exchanger family member and uses therefor |
| 02/26/2003 | EP1285578A2 Transgenic animal model of Alzheimer's disease |
| 02/26/2003 | EP1285577A1 Chimeric mouse having an immune system constructed with human cd34-positive cells and use thereof |
| 02/26/2003 | EP1285390A2 Method and system for the assembly of a whole genome using a shot-gun data set |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285271A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 02/26/2003 | EP1285270A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 02/26/2003 | EP1285269A2 Lipid uptake assays |
| 02/26/2003 | EP1285261A1 Field effect transistor device for ultra-fast nucleic acid sequencing |
| 02/26/2003 | EP1285260A1 Denaturant-free electrophoresis of biological molecules under high temperature conditions |
| 02/26/2003 | EP1285093A2 Single copy genomic hybridization probes and method of generating same |
| 02/26/2003 | EP1285090A1 Detection of nucleotide sequence variations via the proofreading activity of polymerases |
| 02/26/2003 | EP1285089A1 Methods for monitoring the expression of alternatively spliced genes |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285083A1 A process for the fermentative preparation of d-pantothenic acid using coryneform bacteria with deleted pck (phosphoenolpyruvate carboxykinase, 4.1.1.49) gene |
| 02/26/2003 | EP1285081A2 Improved methods of transfection |
| 02/26/2003 | EP1285080A2 Method for the purification of alphavirus replicon particles |
| 02/26/2003 | EP1285079A2 Modified bovine adenovirus having altered tropism |
| 02/26/2003 | EP1285078A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 02/26/2003 | EP1285077A2 Triacylglycerol lipases from arabidopsis thaliana |
| 02/26/2003 | EP1285076A2 Production of silk-like proteins in plants |
| 02/26/2003 | EP1285075A1 Process for the fermentative preparation of l-threonine |
| 02/26/2003 | EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/26/2003 | EP1285073A2 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme |
| 02/26/2003 | EP1285072A2 In vitro fucosylation recombinant glycopeptides |
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285070A1 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular pha depolymerase |
| 02/26/2003 | EP1285069A1 Anti-listeria bacteriocin |
| 02/26/2003 | EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 02/26/2003 | EP1285067A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 02/26/2003 | EP1285066A1 F-box containing protein |
| 02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
| 02/26/2003 | EP1285064A2 G-protein coupled receptors and uses therefor |
| 02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
| 02/26/2003 | EP1285062A1 Vector constructs |
| 02/26/2003 | EP1285061A1 Antisense modulation of pten expression |
| 02/26/2003 | EP1285060A2 26335, a novel human serine/threonine dehydratase and uses thereof |
| 02/26/2003 | EP1285059A2 Adjuvant preparation for the induction of specific immunity |
| 02/26/2003 | EP1285004A1 Synthetic peptides and uses therefore |
| 02/26/2003 | EP1285002A2 REGULATING LIPID LEVELS VIA THE i ZMAX1 /i OR i HBM /i GENE |
| 02/26/2003 | EP1284999A2 Repair of nerve damage |
| 02/26/2003 | EP1284997A2 Therapeutic compounds for ovarian cancer |
| 02/26/2003 | EP1284996A2 Therapeutic anti-melanoma compounds |
| 02/26/2003 | EP1284995A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 02/26/2003 | EP1284993A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 02/26/2003 | EP1284987A2 Methods for refolding proteins containing free cysteine residues |
| 02/26/2003 | EP1284986A1 Javelinization of protein antigens to heat shock proteins |
| 02/26/2003 | EP1284985A2 Plant gene targeting using oligonucleotides |
| 02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
| 02/26/2003 | EP1284747A2 Compositions and methods for achieving immune suppression |
| 02/26/2003 | EP1284746A1 A method of treatment and prophylaxis |
| 02/26/2003 | EP1284720A2 Method of treating hepatitis delta viral infection |
| 02/26/2003 | EP1284597A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides |
| 02/26/2003 | EP1212453A4 Method to identify gene function using small molecule probes |
| 02/26/2003 | EP1141409A4 A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 02/26/2003 | EP0944734B1 Bacillus strain and antibiotic screening method |
| 02/26/2003 | EP0920626B1 Method for isolating a target biological material, capture phase, detecting phase and reagent containing them |
| 02/26/2003 | EP0823914A4 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 02/26/2003 | EP0822986B1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/26/2003 | EP0785277B1 Probe for diagnosing infectious diseases |
| 02/26/2003 | EP0777727B1 Methods of production of Herpes Simplex Virus 1 or 2 protease |
| 02/26/2003 | EP0770137B1 Improvements in production of proteins in host cells |
| 02/26/2003 | EP0768893B1 Polynucleotide vaccine for papillomavirus |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0728191B1 A secretion sequence for the production of a heterologous protein in yeast |